DRGEM Corporation

263690 · KQ · Healthcare / Medical Devices

4,915.00KRW+35.00 (+0.72%)

Price History

Full chart

Market Stats

Previous Close4,880.00

Open4,870.00

Day Range4,870.00 – 4,935.00

52-Week Range4,605.00 – 6,180.00

Volume3.13K

Market Cap56.44B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield3.44%

Beta0.28

50-Day Avg5,028.60

200-Day Avg5,241.50

About

DRGEM Corporation manufactures and sells diagnostic radiography systems. It offers high frequency X-ray generators; conventional and digital radiography systems; and ACQUIDR, a digital imaging system. DRGEM Corporation exports its products. The company was founded in 2003 and is headquartered in Gwangmyeong-si, South Korea.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. JungByung Park
Employees267
HeadquartersE-B/D Gwangmyeong Techno-Park, Gwangmyeong-si, South Korea, 14322, Korea
Websitehttps://www.drgem.co.kr

Leadership

Mr. JungByung ParkCEO & Internal Director · b. 1963
Mr. Jong Sung KimManaging Director · b. 1967
Mr. YoungJin HongManaging Director · b. 1970
Mr. SungChan HongManaging Director · b. 1968
Mr. YoungMin SeoMD & Internal Director · b. 1974
Mr. MinSoo ByeonManaging Director · b. 1973

Financials

Income Statement

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	32.09B	35.35B	49.32B	56.63B	60.09B	106.60B	85.75B	110.17B	112.92B	104.01B	102.75B
Growth (%)	-	+10.17%	+39.51%	+14.81%	+6.11%	+77.41%	-19.56%	+28.47%	+2.50%	-7.89%	-1.21%
Cost of Revenue	24.03B	24.60B	35.86B	40.44B	42.69B	67.82B	58.58B	73.45B	83.30B	73.59B	70.53B
Gross Profit	8.06B	10.75B	13.46B	16.19B	17.40B	38.79B	27.17B	36.71B	29.62B	30.41B	32.21B
Gross Margin	25.12%	30.41%	27.30%	28.59%	28.96%	36.38%	31.69%	33.32%	26.23%	29.24%	31.35%
Operating Expense	6.10B	8.06B	9.31B	11.99B	12.83B	15.80B	14.78B	19.75B	19.55B	21.56B	23.19B
Operating Income	1.96B	2.69B	4.15B	4.21B	4.57B	22.99B	12.39B	16.96B	10.07B	8.85B	9.03B
Operating Margin	6.12%	7.61%	8.42%	7.43%	7.61%	21.57%	14.45%	15.39%	8.92%	8.51%	8.78%
EBITDA	-	-	-	-	-	-	-	18.86B	12.80B	14.63B	9.92B
EBITDA Margin	-	-	-	-	-	-	-	17.12%	11.34%	14.07%	9.66%
Net Income	1.64B	332.71M	3.99B	4.65B	5.47B	19.99B	12.55B	14.39B	9.19B	10.15B	6.78B
Net Income Margin	5.11%	0.94%	8.09%	8.22%	9.10%	18.75%	14.64%	13.06%	8.14%	9.76%	6.60%
R&D	1.85B	1.96B	2.23B	2.77B	2.84B	3.29B	3.90B	5.77B	5.41B	4.88B	6.14B
R&D as % of Total Revenue	5.75%	5.56%	4.51%	4.90%	4.72%	3.09%	4.55%	5.24%	4.79%	4.70%	5.97%
Interest Expense	0	0	0	0	0	115.56M	110.61M	294.63M	389.34M	567.96M	443.57M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.11%	0.13%	0.27%	0.34%	0.55%	0.43%

Balance Sheet

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	23.54B	27.82B	34.41B	46.29B	63.05B	72.63B	84.05B	126.71B	128.41B	122.00B	121.97B
Total Liabilities	15.61B	18.28B	18.75B	17.61B	30.52B	20.10B	23.04B	53.07B	49.09B	35.36B	29.85B
Total Equity	2.18B	9.54B	15.65B	28.68B	32.52B	52.53B	61.01B	73.63B	79.32B	86.65B	92.11B
Cash	2.31B	5.76M	4.09B	8.48B	10.83B	12.41B	23.91M	15.40M	16.96B	19.00M	13.65B
Total Debt	-	-	7.01B	-	5.08B	5.01B	-	-	-	-	-

Cash Flow

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	1.27B	4.53B	2.39B	3.00B	2.98B	10.09B	10.39B	7.35B	14.99B	3.68B	11.61B
Investing Cash Flow	-566.67M	-663.68M	-4.05B	-2.03B	-3.85B	-6.70B	-7.38B	-7.27B	-11.79B	-695.90M	-
Financing Cash Flow	1.14B	-3.20B	2.80B	3.45B	3.26B	-1.59B	-4.11B	17.90B	-14.05B	-3.50B	-
Capital Expenditure	950.09M	483.97M	4.04B	237.49M	1.80B	446.02M	1.43B	15.48B	12.28B	3.62B	4.40B
Free Cash Flow	-	-	-	-	-	8.90B	8.96B	-8.13B	2.71B	54.69M	7.22B
Dividends Paid	37.72M	150.88M	121.19M	782.45M	566.28M	379.50M	2.24B	1.55B	3.49B	1.98B	1.74B
FCF to OCF	-	-	-	-	-	88.15%	86.25%	-110.57%	18.07%	1.49%	62.14%
Dividend Paid to FCF	-	-	-	-	-	4.27%	24.98%	-19.01%	128.92%	3626.18%	24.16%

Earnings

Report Date	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	30.51	130.00	128.57	196.35	285.38	1265.26	85.60	149.66	217.74	310.86	243.52	349.45	318.97	418.40	770.70	-201.68	217.14	359.39	242.22	15.52	341.40	305.52	-91.20	366.41	105.75	83.15	183.11	250.18	365.48	328.21
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap56.44B

Enterprise Value48.07B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.52

Price / Book0.56

Revenue (TTM)109.45B

Gross Profit (TTM)35.12B

EBITDA13.48B

Profit Margin11.22%

Operating Margin11.70%

Return on Equity13.26%

Return on Assets5.29%

Shares Outstanding10.90M

Shares Float4.63M

Beta0.28

Dividend Yield3.44%

Dividend Rate178.00

Payout Ratio15.79%

Dividends

20251×

178.00Dec 29, 2025

20241×

160.00Dec 27, 2024

20231×

180.00Dec 27, 2023

20221×

317.00Dec 28, 2022

20211×

140.00Dec 29, 2021

20201×

200.00Dec 29, 2020

20191×

50.00Dec 27, 2019

20181×

50.00Dec 27, 2018